Company news

Thalia Therapeutics PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

AGM Statement

June 19, 2019

Change to Director Shareholding

May 28, 2019

Board Changes

May 21, 2019

Nuvec® Research update

April 15, 2019

Director/PDMR Shareholding

April 10, 2019

Placing to raise £1.05 million

February 8, 2019

Nuvec licence extension

December 20, 2018

Nuvec® research update

November 28, 2018

Nuvec resource changes

November 16, 2018

Filing of further Nuvec® patent application

November 15, 2018

Research collaboration update

November 5, 2018

Research collaboration for novel DNA vaccine

October 2, 2018

Grant of options

September 26, 2018

Acceptance of Nuvec® on EUNCL

September 24, 2018

Strategic Review

September 20, 2018

Clinical trials preliminary results

July 9, 2018

Nuvec® Update

June 18, 2018

Filing of Patent

May 9, 2018

Commencement of Sildenafil Clinical Trial

April 18, 2018

Exercise of Warrants and Total Voting Rights

March 9, 2018

Issue of Equity and Director/PDMR Shareholding

February 5, 2018

Award of Grant and Collaboration with MedImmune UK

February 2, 2018

Global Business Accelerator Programme in Japan

January 24, 2018

Viagra switch to OTC status in the UK

November 29, 2017

Results of latest nuvec pre-clinical study

November 8, 2017

Sildenafil PCT Update

October 10, 2017

Update on Sildenafil clinical plans

July 27, 2017

Change in Director Details

July 11, 2017

Update on Toxicity Testing of Nuvec® Particles

June 30, 2017

Filing of Patents and Sildenafil Update

May 15, 2017

Admission and First Day of Dealings

May 3, 2017

← Newer news releases

Calls

Decks